Statement by FDA Commissioner Scott Gottlieb, M.D., on balancing access to appropriate treatment for patients with chronic and end-of-life pain with need to take steps to stem misuse and abuse of opioids

FDA Commissioner statement on balancing access to appropriate treatment for patients with chronic and end-of-life pain with need to take steps to stem opioid misuse and abuse.

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm612779.htm

Source: Food and Drug Administration - July 9, 2018 Category: American Health Source Type: news

More News: American Health | Chronic Pain | Food and Drug Administration (FDA) | Pain | Substance Abuse